Strides: Dr R Ananthanarayanan to depart as MD, Arun Kumar to take charge

Published On 2022-03-30 11:03 GMT   |   Update On 2022-03-30 11:03 GMT
Advertisement

Bengaluru: Strides Pharma Science Limited, a global pharmaceutical company, has announced that Dr. R. Ananthanarayanan(Ananth) has decided to depart as Managing Director (MD) and Chief Executive Officer (CEO) of Strides, effective March 31, 2022, to pursue his personal interests outside the organization.

Consequently, Arun Kumar, Founder, will return to Strides in an executive role and assume the position of Executive Chairperson and Managing Director(MD) effective April 7, 2022.

Advertisement

Since January 2020, Ananth has been spearheading Strides and has been driving the strategic decisions around the future design of the organization. The Board of Directors of the Company (Board) accepted Ananth's resignation and thanked him for his leadership, commitment, enthusiasm, and motivation during his tenure at Strides in a challenging global operating environment.

Read also: Strides Pharma, Medicines Patent Pool ink pact to commercialize molnupiravir for global markets

Commenting on the updates, Arun Kumar remarked, "We thank Ananth for his leadership during his tenure at Strides in a tough global operating environment. Ananth has been closely working with the Board to recalibrate the growth and profitability of the Company and our priority is to continue building on those strategic and operational initiatives. The Company remains committed to enabling a fast turnaround of its business performance and delivering sustainable outcomes. " 

Read also: Strides Pharma gets USFDA nod for colchicine tablets 

Strides is a global pharmaceutical company headquartered in Bengaluru, India. The Company mainly operates in the regulated markets and has an "in Africa for Africa" strategy and an institutional business to service donor‐funded markets. The Company's global manufacturing sites are located in India (Chennai, Puducherry and two locations in Bengaluru), Singapore, Italy (Milan), Kenya (Nairobi), and the United States (New York). The Company focuses on "difficult to manufacture" products sold in over 100 countries.

Read also: Ms. Chandra Ganjoo to lead Trivitron Healthcare as Group CEO 

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News